1. Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. Issue 3 (8th July 2020) Authors: Reyes-Uribe, Laura; Wu, Wenhui; Gelincik, Ozkan; Bommi, Prashant V; Francisco-Cruz, Alejandro; Solis, Luisa M; Lynch, Patrick M; Lim, Ramona; Stoffel, Elena M; Kanth, Priyanka; Samadder, N Jewel; Mork, Maureen E; Taggart, Melissa W; Milne, Ginger L; Marnett, Lawrence J; Vornik, Lana; Liu, Diane D... Journal: Gut Issue: Volume 70:Issue 3(2021) Page Start: 555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis. Issue 2 (30th May 2022) Authors: Samadder, N Jewel; Foster, Nathan; McMurray, Ryan P; Burke, Carol A; Stoffel, Elena; Kanth, Priyanka; Das, Rohit; Cruz-Correa, Marcia; Vilar, E; Mankaney, Gautam; Buttar, Navtej; Thirumurthi, Selvi; Turgeon, Danielle K; Sossenheimer, Michael; Westover, Michelle; Richmond, Ellen; Umar, Asad; Della... Journal: Gut Issue: Volume 72:Issue 2(2023) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗